PrideRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: tirzepatide from $299/month
PrideRx's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
The first month of membership costs $25; after that it is $99/mo, buying doctor visits and prescription management while the pharmacy invoices the drug on its own. Only brand-name GLP-1 products are sold: Foundayo (orforglipron) at $149/mo, oral semaglutide as the Wegovy Pill at $149/mo too, and Zepbound (tirzepatide) from $299/mo, each fulfilled straight through LillyDirect and NovoCare. PrideRx presents itself as LGBTQ+-friendly and also handles sexual health, PrEP and hair loss.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to PrideRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
PrideRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Tirzepatide, Semaglutide, Orforglipron
- Starting price
- $149/mo (Wegovy Pill (oral semaglutide) via NovoCare from $149/mo; plus $25 first month then $99/mo PrideRx membership. Verifi...)
- FDA status
- No FDA warning letter on record
How PrideRx scores
Six columns, each one computed from something PrideRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
5.0/10Every published price sits implausibly far below the register median, which usually means a promotional rate or a fee recorded as a monthly cost. Held at the midpoint pending re-verification rather than rewarded.
Effectiveness25%
10.0/10Dispenses orforglipron and semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
6.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on PrideRx
Last checked August 2026- Re-read the price on file across 3 dose or plan tiers
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with PrideRx involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1PrideRx publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3PrideRx does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- Cheapest standing monthly prices on record: tirzepatide $299. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether PrideRx serves your state cannot be confirmed from its site.
PrideRx support, as documented
- support@priderx.com
GLP-1 medications PrideRx offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Zepbound KwikPen via LillyDirect, $299/mo at 2.5mg up to $449/mo at 7.5mg+; plus $25 first month then $99/mo PrideRx membership. Verified priderx.com/zepbound 2026-06-05 (site: 'Prices verified 3/9/2026')
Wegovy Pill (oral semaglutide) via NovoCare from $149/mo; plus $25 first month then $99/mo PrideRx membership. Verified priderx.com/wegovy 2026-06-05
Foundayo (orforglipron) via LillyDirect, $149/mo starter up to $299/mo at higher doses; plus $25 first month then $99/mo PrideRx membership. Verified priderx.com/foundayo 2026-06-05
Check the price yourself before you pay
Every figure here was read off PrideRx's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide at $299 a month, 76% below the $1249 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
What PrideRx charges
The standing price at PrideRx is $149/month. That sits at the affordable end of what we track.
- Brand-name tirzepatide — $299/month
- Brand-name semaglutide — $149/month
- Brand-name orforglipron — $149/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so PrideRx is genuinely under the middle rather than merely advertising that it is.
Found, at about $149/month, is the closest thing we track to a like-for-like alternative.
What PrideRx dispenses
PrideRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the vial has been reviewed.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at PrideRx at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.
What we could verify
PrideRx publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
- injections are the thing keeping you from starting
Our read
PrideRx competes on price and does it without an obvious sacrifice elsewhere: $149/month, no warning letter on file, and access that is not unusually restricted.
The Bottom Line
PrideRx's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Before you pay PrideRx
Starting at $149/month. Check today's price, then book the free consultation.
Where PrideRx is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this PrideRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See PrideRx's current pricing
Plans start at $149/month. The free consultation is where you learn whether you qualify, and what it costs today.